203 related articles for article (PubMed ID: 32726404)
21. Prospective evaluation of the association of nut/peanut consumption with total and cause-specific mortality.
Luu HN; Blot WJ; Xiang YB; Cai H; Hargreaves MK; Li H; Yang G; Signorello L; Gao YT; Zheng W; Shu XO
JAMA Intern Med; 2015 May; 175(5):755-66. PubMed ID: 25730101
[TBL] [Abstract][Full Text] [Related]
22. Dietary acrylamide intake and the risk of colorectal cancer with specific mutations in KRAS and APC.
Hogervorst JG; de Bruijn-Geraets D; Schouten LJ; van Engeland M; de Kok TM; Goldbohm RA; van den Brandt PA; Weijenberg MP
Carcinogenesis; 2014 May; 35(5):1032-8. PubMed ID: 24398672
[TBL] [Abstract][Full Text] [Related]
23. Associations of total nut and peanut intakes with all-cause and cause-specific mortality in a Japanese community: the Takayama study.
Yamakawa M; Wada K; Koda S; Uji T; Nakashima Y; Onuma S; Oba S; Nagata C
Br J Nutr; 2022 May; 127(9):1378-1385. PubMed ID: 34225833
[TBL] [Abstract][Full Text] [Related]
24. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer.
de Vogel S; Bongaerts BW; Wouters KA; Kester AD; Schouten LJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; van Engeland M; Weijenberg MP
Carcinogenesis; 2008 Sep; 29(9):1765-73. PubMed ID: 18339680
[TBL] [Abstract][Full Text] [Related]
25. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
[TBL] [Abstract][Full Text] [Related]
26. External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.
Alwers E; Bläker H; Walter V; Jansen L; Kloor M; Arnold A; Sieber-Frank J; Herpel E; Tagscherer KE; Roth W; Chang-Claude J; Brenner H; Hoffmeister M
BMC Cancer; 2019 Jul; 19(1):681. PubMed ID: 31296182
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
28. The relationship between nut intake and risk of colorectal cancer: a case control study.
Lee J; Shin A; Oh JH; Kim J
Nutr J; 2018 Mar; 17(1):37. PubMed ID: 29514652
[TBL] [Abstract][Full Text] [Related]
29. Molecular subtypes of colorectal cancers determined by PCR-based analysis.
Sugai T; Eizuka M; Takahashi Y; Fukagawa T; Habano W; Yamamoto E; Akasaka R; Otuska K; Matsumoto T; Suzuki H
Cancer Sci; 2017 Mar; 108(3):427-434. PubMed ID: 28083970
[TBL] [Abstract][Full Text] [Related]
30. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
[TBL] [Abstract][Full Text] [Related]
31. Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC.
Gilsing AM; Fransen F; de Kok TM; Goldbohm AR; Schouten LJ; de Bruïne AP; van Engeland M; van den Brandt PA; de Goeij AF; Weijenberg MP
Carcinogenesis; 2013 Dec; 34(12):2757-66. PubMed ID: 23983135
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.
Amitay EL; Carr PR; Jansen L; Alwers E; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Int J Cancer; 2020 Aug; 147(4):1018-1026. PubMed ID: 31943160
[TBL] [Abstract][Full Text] [Related]
33. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
Myte R; Gylling B; Häggström J; Häggström C; Zingmark C; Löfgren Burström A; Palmqvist R; Van Guelpen B
Int J Cancer; 2019 Jul; 145(2):327-337. PubMed ID: 30613980
[TBL] [Abstract][Full Text] [Related]
34. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes.
Li TY; Brennan AM; Wedick NM; Mantzoros C; Rifai N; Hu FB
J Nutr; 2009 Jul; 139(7):1333-8. PubMed ID: 19420347
[TBL] [Abstract][Full Text] [Related]
35. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.
Hughes LA; Williamson EJ; van Engeland M; Jenkins MA; Giles GG; Hopper JL; Southey MC; Young JP; Buchanan DD; Walsh MD; van den Brandt PA; Alexandra Goldbohm R; Weijenberg MP; English DR
Int J Epidemiol; 2012 Aug; 41(4):1060-72. PubMed ID: 22531127
[TBL] [Abstract][Full Text] [Related]
36. Associations of Nut Intakes with Incident Sporadic Colorectal Adenoma: A Pooled Case-Control Study.
Yin X; Bostick RM
Nutr Cancer; 2019; 71(5):731-738. PubMed ID: 30372131
[TBL] [Abstract][Full Text] [Related]
37. Associations between nut consumption and inflammatory biomarkers.
Yu Z; Malik VS; Keum N; Hu FB; Giovannucci EL; Stampfer MJ; Willett WC; Fuchs CS; Bao Y
Am J Clin Nutr; 2016 Sep; 104(3):722-8. PubMed ID: 27465378
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
39. Coaltered
Datta J; Smith JJ; Chatila WK; McAuliffe JC; Kandoth C; Vakiani E; Frankel TL; Ganesh K; Wasserman I; Lipsyc-Sharf M; Guillem J; Nash GM; Paty PB; Weiser MR; Saltz LB; Berger MF; Jarnagin WR; Balachandran V; Kingham TP; Kemeny NE; Cercek A; Garcia-Aguilar J; Taylor BS; Viale A; Yaeger R; Solit DB; Schultz N; D'Angelica MI
Clin Cancer Res; 2020 Mar; 26(5):1077-1085. PubMed ID: 31719050
[TBL] [Abstract][Full Text] [Related]
40. Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.
Dimberg J; Andersson RE; Haglund S
Oncology; 2020; 98(8):575-582. PubMed ID: 32408300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
